BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380 | -7.5% | 125 | 0.0% | 0.00% | – |
| Q2 2023 | $411 | +3.3% | 125 | 0.0% | 0.00% | – |
| Q1 2023 | $398 | -54.0% | 125 | 0.0% | 0.00% | – |
| Q4 2022 | $865 | -13.5% | 125 | -5.3% | 0.00% | -100.0% |
| Q3 2022 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,000 | -66.7% | 132 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $3,000 | -25.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 132 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | +300.0% | 132 | +450.0% | 0.00% | +100.0% |
| Q4 2020 | $1,000 | 0.0% | 24 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,000 | -75.0% | 24 | -42.9% | 0.00% | -66.7% |
| Q3 2019 | $4,000 | -33.3% | 42 | -10.6% | 0.00% | -25.0% |
| Q2 2019 | $6,000 | -14.3% | 47 | 0.0% | 0.00% | -20.0% |
| Q1 2019 | $7,000 | -30.0% | 47 | -29.9% | 0.01% | 0.0% |
| Q3 2018 | $10,000 | – | 67 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Monashee Investment Management LLC | 125,000 | $13,131,000 | 5.55% |
| Cormorant Asset Management, LP | 275,000 | $28,889,000 | 4.79% |
| Eventide Asset Management | 569,700 | $59,847,000 | 3.73% |
| Crosspoint Capital Strategies, LLC | 28,937 | $3,040,000 | 2.66% |
| Casdin Capital, LLC | 65,000 | $6,828,000 | 2.53% |
| ARK Investment Management | 119,683 | $12,573,000 | 2.45% |
| RTW INVESTMENTS, LP | 104,383 | $10,965,000 | 2.31% |
| Taylor Wealth Management Partners | 38,368 | $4,031,000 | 1.82% |
| First Light Asset Management, LLC | 33,780 | $3,549,000 | 1.19% |
| Atika Capital Management LLC | 25,000 | $2,627,000 | 0.92% |